This funding supports the creation of a Center dedicated to training researchers in formal product development for substance use disorder pharmacotherapeutics. It also provides technical and financial support to advance the best concepts through initial preclinical experiments. Clinical trials are not allowed under this U54 mechanism.
Eligible applicants include a wide range of organizations such as for-profit entities (excluding small businesses), various government levels, tribal governments and organizations, nonprofits, private and public institutions of higher education, school districts, small businesses, and housing author